BEGIN:VCALENDAR X-WR-TIMEZONE:US/Eastern DTSTART:20190416T130000 DTEND:20190416T140000 VERSION:2.0 LOCATION:OnlinePRODID:-//Training Doyens //EN METHOD:REQUEST BEGIN:VEVENT UID:20190416T000000-1010373911-example.com DTSTAMP:20190416T000000 DTSTART;TZID="US/Eastern":20190416T130000 DTEND;TZID="US/Eastern":20190416T140000 SUMMARY:FDA 21 CFR Part 11 Compliance: Streamline Your Transition to Electronic Records DESCRIPTION: FDA regulated companies want to transition to electronic records for economy and efficiency. FDA, because of its concern for patient safety, wants to prevent electronic records from being compromised with possible resulting harm to the patient. FDA has set up regulations that address both data security and patient safety. We will show how FDA 21 CFR Part 11 compliance checklist considers both. The confusion over the original FDA regulation and its subsequent “selective enforcement” will be explained. FDA requirements for electronic record and signature validation will be explained. The requirements are composed of technical and procedural aspects. Open, closed and hybrid (paper and electronic) systems will be explained. PRIORITY:3END:VEVENT END:VCALENDAR